Atrial-specific drug AVE0118 is free of torsades de pointes in anesthetized dogs with chronic complete atrioventricular block

This publication has 25 references indexed in Scilit:

• Drug therapy for atrial fibrillation: where do we go from here?
  Nature Reviews Drug Discovery, 2005
• Diverse phenotypes of outward currents in cells that have survived in the 5-day-infarcted heart
  American Journal of Physiology-Heart and Circulatory Physiology, 2005
• Atrial‐Specific Drugs:
  Journal of Cardiovascular Electrophysiology, 2004
• Role of I _Kur in Controlling Action Potential Shape and Contractility in the Human Atrium
  Circulation, 2004
• Effects of the atrial antiarrhythmic drug AVE0118 on cardiac ion channels
  Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 2004
• New ideas about atrial fibrillation 50 years on
  Nature, 2002
• Distribution of the Muscarinic K⁺ Channel Proteins Kir3.1 and Kir3.4 in the Ventricle, Atrium, and Sinoatrial Node of Heart
  Journal of Histochemistry & Cytochemistry, 2001
• Atrial Fibrillation and Stroke
  Stroke, 2001
• Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications
  Archives of internal medicine (1960), 1995
• Sustained depolarization-induced outward current in human atrial myocytes. Evidence for a novel delayed rectifier K+ current similar to Kv1.5 cloned channel currents.
  Circulation Research, 1993